Otofarma takes over plant in Corsico (Milan): aims to double production

The Otofarma Group will open a new plant in Milan. The Neapolitan-based company has signed the final purchase agreement for a new plant in Corsico, in the Milan metropolitan area. The 1.5 million investment meets the need of the group, with over 30 years of experience in the hearing care sector and among the leaders in the production of hearing aids, to expand production. This operation marks a fundamental step in Otofarma's industrial growth path.

The industrial plan envisages doubling the company's production capacity, further strengthening Otofarma's position among the leading players in the production of hearing aids in Italia.

The new site, with an area of approximately 3,000 square metres, will be mainly dedicated to the production of Otofarma-branded devices and will be equipped with state-of-the-art technology for the production of customised hearing aids. The expansion will significantly increase production volumes and improve operational efficiency.

The operation responds to the growing demand recorded in recent years, supported both by the increase in the number of hearing impaired patients and the success of the distribution model based on a network of 4,462 affiliated pharmacies (as at 31 December 2025). Thanks to its presence in a strategic area of its target market, the new plant will also make it possible to reduce delivery times, increase the ability to customise devices and enhance the flexibility of the entire industrial chain.

The Corsico site will not replace the existing facilities, but will complement and strengthen their activities, supporting continuous growth without impacting ongoing production. The sales and marketing offices are scheduled to start up by 2027, while the first production lines are expected to be operational by 2028.